
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases
Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine
Description
Key Features
- Presents the first comprehensive, tabulated summary of literature on the epidemiological data on smoking and neurological disease
- Includes preclinical and clinical data on nicotine in neurological diseases and mechanisms of action of nicotine in neuroprotection
- Features a comprehensive summary of non-nicotine smoke constituents with potentially neuroprotective and anti-inflammatory properties
- Discusses Multiple Sclerosis, Alzheimer’s disease, Parkinson’s Disease, Schizophrenia, Depression, ADHD, Anxiety and Tourette’s Syndrome in the context of smoking and nicotine
Readership
Table of Contents
Foreword
Introduction
Search Methods
- Parkinson’s disease
- Alzheimer's disease
- Multiple sclerosis
- Schizophrenia
- Tourette syndrome
- Attention Deficit Hyperactivity Disorder
- Depression
- Anxiety
- Nicotine
- Other Compounds from Tobacco with Potential Impact on Neurodegenerative Diseases
- Research Models of Neurodegenerative Diseases: Major Considerations for Translatibility
- Concluding Remarks
-Symptoms and epidemiology of Parkinson’s disease (high level), molecular mechanisms and focusing on impact of smoking providing a comprehensive tables with clinical and nonclinical evidences of impact of nicotine
-Symptoms and epidemiology of Alzheimer’s disease (high level), molecular mechanisms and focusing on impact of smoking providing a comprehensive tables with clinical and nonclinical evidences of impact of nicotine
-Symptoms and epidemiology of multiple sclerosis, molecular mechanisms and impact of smoking and nicotine Tourette syndrome
-High level description of symptoms and epidemiology of the disease, some molecular mechanisms, impact of smoking with clinical evidences, impact of nicotine with clinical and non-clinical evidences
-Symptoms, epidemiology and potential causes of Tourette’s syndrome (high level), focusing on impact of smoking providing a comprehensive tables with clinical and nonclinical evidences of impact of nicotine
-Symptoms, epidemiology and potential causes of ADHD (high level), focusing on impact of smoking providing a comprehensive tables with clinical and nonclinical evidences of impact of nicotine
-Symptoms, epidemiology and potential causes, impact of smoking and nicotine
-Symptoms, epidemiology and potential causes, impact of smoking and nicotine
-Impact of nicotine on cognitive functions, nicotinic acetylcholine receptors, nicotine effects on neurotransmitter systems and on cellular molecular signaling, nAChRs in mitochondria, nAChRs in neural stem cells and in microglia and transmembrane transport of nicotine
-nAChRs agonists, MAO inhibitors in therapy of neurodegenerative diseases, other tobacco compounds and neuroprotection: Cotinine, Anatabine, anabasine and other tobacco alkaloids, Cembranoids, Scopoletin, Eugenol, Rutin, Ferulic acid, Chlorogenic acid, β-Carboline, Resorcinol, β-sitosterol, Quinoline, Sinapyl alcohol, Caffeic acid
Product details
- No. of pages: 164
- Language: English
- Copyright: © Academic Press 2018
- Published: January 2, 2018
- Imprint: Academic Press
- eBook ISBN: 9780128129234
- Hardcover ISBN: 9780128129227
About the Authors
Emilija Veljkovic

Affiliations and Expertise
Wenhao Xia

Affiliations and Expertise
Blaine Phillips

Affiliations and Expertise
Ee Wong

Affiliations and Expertise
Jenny Ho

Affiliations and Expertise
Alberto Oviedo

Affiliations and Expertise
Julia Hoeng

Affiliations and Expertise
Manuel Peitsch

Affiliations and Expertise
Ratings and Reviews
Latest reviews
(Total rating for all reviews)
Emilija V. Sun May 12 2019
Excellent
Excellent